Shifting trends in liver-directed management of patients with colorectal liver metastasis: A population-based analysis

Surgery

Volumn 150, Issue 2, 2011, Pages 204-216

  Mayo, Skye C ^a   Heckman, Jennifer E ^a   Shore, Andrew D ^a   Nathan, Hari ^a   Parikh, Alexander A ^b   Bridges, John F P ^a   Anders, Robert A ^c   Anaya, Daniel A ^d   Becker, Natasha S ^d   Pawlik, Timothy M ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER SURGERY; CLINICAL EVALUATION; COLORECTAL CANCER; COLORECTAL LIVER METASTASIS; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERIOPERATIVE COMPLICATION; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL;

AGED; ANTINEOPLASTIC AGENTS; CATHETER ABLATION; COLORECTAL NEOPLASMS; COMORBIDITY; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; RETROSPECTIVE STUDIES; SEER PROGRAM; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; UNITED STATES;

EID: 79960898792     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2011.06.013     Document Type: Article

References (54)

1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M.J. Thun Cancer Statistics, 2009 CA Cancer J Clin 59 2009 225 249
2. J. Norstein, and W. Silen Natural history of liver metastases from colorectal carcinoma J Gastrointest Surg 1 1997 398 407 (Pubitemid 127432787)
3. L.H. Blumgart, and D.J. Allison Resection and embolization in the management of secondary hepatic tumors World J Surg 6 1982 32 45 (Pubitemid 12066479)
4. I. Taylor, M.A. Mullee, and M.J. Campbell Prognostic index for the development of liver metastases in patients with colorectal cancer Br J Surg 77 1990 499 501 (Pubitemid 20164688)
5. Y. Fong, J. Fortner, R.L. Sun, M.F. Brennan, and L.H. Blumgart Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases Ann Surg 230 1999 309 318
6. M.C. de Jong, M.G. van Vledder, D. Ribero, C. Hubert, J.F. Gigot, and M.A. Choti Therapeutic efficacy of combined intraoperative ablation and resection for colorectal liver metastases: an international, multi-institutional analysis J Gastrointest Surg 15 2011 336 344
7. M.C. de Jong, C. Pulitano, D. Ribero, J. Strub, G. Mentha, and R.D. Schulick Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients Ann Surg 250 2009 440 448
8. S.A. Curley, P. Marra, K. Beaty, L.M. Ellis, J.N. Vauthey, and E.K. Abdalla Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients Ann Surg 239 2004 450 458 (Pubitemid 38372760)
9. T.M. Pawlik, R.D. Schulick, and M.A. Choti Expanding criteria for resectability of colorectal liver metastases Oncologist 13 2008 51 64 (Pubitemid 351206696)
10. T.M. Pawlik, and M.A. Choti Surgical therapy for colorectal metastases to the liver J Gastrointest Surg 11 2007 1057 1077
11. R.N. Berri, and E.K. Abdalla Curable metastatic colorectal cancer: recommended paradigms Curr Oncol Rep 11 2009 200 208
12. E.K. Abdalla, J.N. Vauthey, L.M. Ellis, V. Ellis, R. Pollock, and K.R. Broglio Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases Ann Surg 239 2004 818 825
13. M.A. Choti, J.V. Sitzmann, M.F. Tiburi, W. Sumetchotimetha, R. Rangsin, and R.D. Schulick Trends in long-term survival following liver resection for hepatic colorectal metastases Ann Surg 235 2002 759 766 (Pubitemid 34547293)
14. Y. Fong, A.M. Cohen, J.G. Fortner, W.E. Enker, A.D. Turnbull, and D.G. Coit Liver resection for colorectal metastases J Clin Oncol 15 1997 938 946 (Pubitemid 27106275)
15. S. Ambiru, M. Miyazaki, T. Isono, H. Ito, K. Nakagawa, and H. Shimizu Hepatic resection for colorectal metastases: analysis of prognostic factors Dis Colon Rectum 42 1999 632 639 (Pubitemid 29228409)
16. T.A. Aloia, J.N. Vauthey, E.M. Loyer, D. Ribero, T.M. Pawlik, and S.H. Wei Solitary colorectal liver metastasis: resection determines outcome Arch Surg 141 2006 460 466
17. L.C. Cummings, J.D. Payes, and G.S. Cooper Survival after hepatic resection in metastatic colorectal cancer: a population-based study Cancer 109 2007 718 726 (Pubitemid 46233233)
18. S. Kopetz, G.J. Chang, M.J. Overman, C. Eng, D.J. Sargent, and D.W. Larson Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy J Clin Oncol 27 2009 3677 3683
19. G.S. Cooper, B. Virnig, C.N. Klabunde, N. Schussler, J. Freeman, and J.L. Warren Use of SEER-Medicare data for measuring cancer surgery Med Care 40 8 Suppl 2002 IV-43 IV-48
20. National Cancer Institute D, Surveillance Research Program, Cancer Statistics Branch. Surveillance, epidemiology, and end results (SEER) program (http://www.seer.cancer.gov/) SEER Stat database: Incidence, SEER 17 regs public-use, Nov 2005 sub (1973-2003 varying), linked to county attributes, total U.S., 1969-2003 counties. Released April 2006, based on the November 2005 submission.
21. J.L. Warren, C.N. Klabunde, D. Schrag, P.B. Bach, and G.F. Riley Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population Med Care 40 8 Suppl 2002 IV-3 IV18
22. A.G. Fritz International classification of diseases for oncology: ICD-O 3rd ed. 2000 World Health Organization Geneva
23. N.S. Becker, P. Richardson, N.S. Abraham, and D.A. Anaya Identification of patients with colorectal liver metastases using administrative databases. Abstracts of the Fifth Annual Academic Surgical Congress of the Association for Academic Surgery and Society of University Surgeons. San Antonio, Texas, USA. February 3-5, 2010 J Surg Res 158 2010 171 424
24. A.L. Potosky, J.L. Warren, E.R. Riedel, C.N. Klabunde, C.C. Earle, and C.B. Begg Measuring complications of cancer treatment using the SEER-Medicare data Med Care 40 8 Suppl 2002 IV-62 IV-68
25. A. Elixhauser, C. Steiner, D.R. Harris, and R.M. Coffey Comorbidity measures for use with administrative data Med Care 36 1998 8 27 (Pubitemid 128456396)
26. L.M. Baldwin, C.N. Klabunde, P. Green, W. Barlow, and G. Wright In search of the perfect comorbidity measure for use with administrative claims data: does it exist? Med Care 44 2006 745 753 (Pubitemid 44284265)
27. B. Li, D. Evans, P. Faris, S. Dean, and H. Quan Risk adjustment performance of Charlson and Elixhauser comorbidities in ICD-9 and ICD-10 administrative databases BMC Health Serv Res 8 2008 12
28. H. Quan, G.A. Parsons, and W.A. Ghali Validity of information on comorbidity derived from ICD-9-CCM administrative data Med Care 40 2002 675 685
29. D.A. Southern, H. Quan, and W.A. Ghali Comparison of the Elixhauser and Charlson/Deyo methods of comorbidity measurement in administrative data Med Care 42 2004 355 360
30. A. Agresti Introduction to categorical data analysis 1996 Wiley New York 231-6
31. Kaplan EL MP. Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
32. D. Cox Regression models and life tables J R Stat Soc B 34 1972 187 220
33. D.W. Hosmer, and S. Lemeshow Applied Survival Analysis: Regression modeling of time to event data 2nd ed. 1999 John Wiley and Sons New York
34. D.W. Hosmer, and S. Lemeshow Applied logistic regression 2nd ed. 2000 John Wiley and Sons New York
35. S. Lemeshow, and D.W. Hosmer Jr. A review of goodness of fit statistics for use in the development of logistic regression models Am J Epidemiol 115 1982 92 106 (Pubitemid 12205725)
36. R. Adam, R.J. de Haas, D.A. Wicherts, T.A. Aloia, V. Delvart, and D. Azoulay Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement? J Clin Oncol 26 2008 3672 3680
37. B. Asiyanbola, D. Chang, A.L. Gleisner, H. Nathan, M.A. Choti, and R.D. Schulick Operative mortality after hepatic resection: are literature-based rates broadly applicable? J Gastrointest Surg 12 2008 842 851
38. X. Wang, D.L. Hershman, J.A. Abrams, D. Feingold, V.R. Grann, and J.S. Jacobson Predictors of survival after hepatic resection among patients with colorectal liver metastasis Br J Cancer 97 2007 1606 1612 (Pubitemid 350249362)
39. S.C. Mayo, A.D. Shore, H. Nathan, B. Edil, C.L. Wolfgang, and K. Hirose National trends in the management and survival of surgically managed gallbladder adenocarcinoma over 15 years: a population-based analysis J Gastrointest Surg 14 2010 1578 1591
40. H. Nathan, and T.M. Pawlik Limitations of claims and registry data in surgical oncology research Ann Surg Oncol 15 2008 415 423
41. L.K. Temple, L. Hsieh, W.D. Wong, L. Saltz, and D. Schrag Use of surgery among elderly patients with stage IV colorectal cancer J Clin Oncol 22 2004 3475 3484 (Pubitemid 41103653)
42. Y. Nagano, K. Nojiri, K. Matsuo, K. Tanaka, S. Togo, and H. Ike The impact of advanced age on hepatic resection of colorectal liver metastases J Am Coll Surg 201 2005 511 516 (Pubitemid 41393071)
43. K. Nojiri, Y. Nagano, K. Tanaka, K. Matsuo, S. Yamagishi, and M. Ota Validity of hepatic resection of colorectal liver metastases in the elderly (75 years and older) Anticancer Res 29 2009 583 588
44. M.C. Niekel, S. Bipat, and J. Stoker Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment Radiology 257 2010 674 684
45. R.H. Huebner, K.C. Park, J.E. Shepherd, J. Schwimmer, J. Czernin, and M.E. Phelps A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer J Nucl Med 41 2000 1177 1189 (Pubitemid 30464000)
46. T.M. Pawlik, L. Assumpcao, J.A. Vossen, M. Buijs, A.L. Gleisner, and R.D. Schulick Trends in nontherapeutic laparotomy rates in patients undergoing surgical therapy for hepatic colorectal metastases Ann Surg Oncol 16 2009 371 378
47. B. Wiering, E.M. Adang, J.R. van der Sijp, R.M. Roumen, K.P. de Jong, and E.F. Comans Added value of positron emission tomography imaging in the surgical treatment of colorectal liver metastases Nucl Med Commun 31 2010 938 944
48. D.A. Podoloff, R.H. Advani, C. Allred, A.B. Benson 3rd, E. Brown, and H.J. Burstein NCCN task force report: positron emission tomography (PET)/computed tomography (CT) scanning in cancer J Natl Compr Canc Netw 5 Suppl 1 2007 S1 22
49. B. Nordlinger, H. Sorbye, B. Glimelius, G.J. Poston, P.M. Schlag, and P. Rougier Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial Lancet 371 2008 1007 1016 (Pubitemid 351392040)
50. D. Sargent, A. Sobrero, A. Grothey, M.J. O'Connell, M. Buyse, and T. Andre Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials J Clin Oncol 27 2009 872 877
51. T. Andre, C. Boni, L. Mounedji-Boudiaf, M. Navarro, J. Tabernero, and T. Hickish Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer N Engl J Med 350 2004 2343 2351 (Pubitemid 38702845)
52. T.M. Wildes, D. Kallogjeri, B. Powers, A. Vlahiotis, M. Mutch, and E.L. Spitznagel The benefit of adjuvant chemotherapy in elderly patients with stage III colorectal cancer is independent of age and comorbidity J Geriatr Oncol 1 2010 48 56
53. M.C. de Jong, S.C. Mayo, C. Pulitano, S. Lanella, D. Ribero, and J. Strub Repeat curative intent liver surgery is safe and effective for recurrent colorectal liver metastasis: results from an international multi-institutional analysis J Gastrointest Surg 13 2009 2141 2151
54. J.N. Vauthey, T.M. Pawlik, E.K. Abdalla, J.F. Arens, R.A. Nemr, and S.H. Wei Is extended hepatectomy for hepatobiliary malignancy justified? Ann Surg 239 2004 722 730